ID   RPAC1_HUMAN             Reviewed;         346 AA.
AC   O15160; O75395; Q5JTE3;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   10-MAY-2017, entry version 180.
DE   RecName: Full=DNA-directed RNA polymerases I and III subunit RPAC1;
DE            Short=DNA-directed RNA polymerase I subunit C;
DE            Short=RNA polymerases I and III subunit AC1;
DE   AltName: Full=AC40;
DE   AltName: Full=DNA-directed RNA polymerases I and III 40 kDa polypeptide;
DE            Short=RPA40;
DE   AltName: Full=RPA39;
DE   AltName: Full=RPC40;
GN   Name=POLR1C; Synonyms=POLR1E;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9540830; DOI=10.1016/S0167-4781(97)00206-6;
RA   Dammann R., Pfeifer G.P.;
RT   "Cloning and characterization of the human RNA polymerase I subunit
RT   hRPA40.";
RL   Biochim. Biophys. Acta 1396:153-157(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Umbilical cord blood;
RX   PubMed=9653160; DOI=10.1073/pnas.95.14.8175;
RA   Mao M., Fu G., Wu J.-S., Zhang Q.-H., Zhou J., Kan L.-X., Huang Q.-H.,
RA   He K.-L., Gu B.-W., Han Z.-G., Shen Y., Gu J., Yu Y.-P., Xu S.-H.,
RA   Wang Y.-X., Chen S.-J., Chen Z.;
RT   "Identification of genes expressed in human CD34(+) hematopoietic
RT   stem/progenitor cells by expressed sequence tags and efficient full-
RT   length cDNA cloning.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:8175-8180(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 2-11; 14-22; 79-91; 110-120; 155-167 AND 225-255,
RP   CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT ALA-2, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Ovarian carcinoma;
RA   Bienvenut W.V., Lilla S., von Kriegsheim A., Lempens A., Kolch W.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [6]
RP   IDENTIFICATION IN THE RNA POL III COMPLEX, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=12391170; DOI=10.1128/MCB.22.22.8044-8055.2002;
RA   Hu P., Wu S., Sun Y., Yuan C.-C., Kobayashi R., Myers M.P.,
RA   Hernandez N.;
RT   "Characterization of human RNA polymerase III identifies orthologues
RT   for Saccharomyces cerevisiae RNA polymerase III subunits.";
RL   Mol. Cell. Biol. 22:8044-8055(2002).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   SUBCELLULAR LOCATION, SUBUNIT, FUNCTION, INVOLVEMENT IN HLD11,
RP   VARIANTS HLD11 ILE-26; ILE-32; VAL-65; SER-74; ALA-94; HIS-109;
RP   ASP-132; ARG-146; GLN-191; THR-262; LYS-295 DEL AND LYS-324,
RP   CHARACTERIZATION OF VARIANTS HLD11 ILE-32 AND SER-74, AND
RP   CHARACTERIZATION OF VARIANT TCS3 GLN-279.
RX   PubMed=26151409; DOI=10.1038/ncomms8623;
RA   Thiffault I., Wolf N.I., Forget D., Guerrero K., Tran L.T.,
RA   Choquet K., Lavallee-Adam M., Poitras C., Brais B., Yoon G.,
RA   Sztriha L., Webster R.I., Timmann D., van de Warrenburg B.P.,
RA   Seeger J., Zimmermann A., Mate A., Goizet C., Fung E.,
RA   van der Knaap M.S., Fribourg S., Vanderver A., Simons C., Taft R.J.,
RA   Yates J.R. III, Coulombe B., Bernard G.;
RT   "Recessive mutations in POLR1C cause a leukodystrophy by impairing
RT   biogenesis of RNA polymerase III.";
RL   Nat. Commun. 6:7623-7632(2015).
RN   [14]
RP   VARIANTS TCS3 GLN-279 AND TRP-279.
RX   PubMed=21131976; DOI=10.1038/ng.724;
RA   Dauwerse J.G., Dixon J., Seland S., Ruivenkamp C.A., van Haeringen A.,
RA   Hoefsloot L.H., Peters D.J., Boers A.C., Daumer-Haas C., Maiwald R.,
RA   Zweier C., Kerr B., Cobo A.M., Toral J.F., Hoogeboom A.J.,
RA   Lohmann D.R., Hehr U., Dixon M.J., Breuning M.H., Wieczorek D.;
RT   "Mutations in genes encoding subunits of RNA polymerases I and III
RT   cause Treacher Collins syndrome.";
RL   Nat. Genet. 43:20-22(2011).
CC   -!- FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription
CC       of DNA into RNA using the four ribonucleoside triphosphates as
CC       substrates. Common component of RNA polymerases I and III which
CC       synthesize ribosomal RNA precursors and small RNAs, such as 5S
CC       rRNA and tRNAs, respectively. RPAC1 is part of the Pol core
CC       element with the central large cleft and probably a clamp element
CC       that moves to open and close the cleft (By similarity).
CC       {ECO:0000250|UniProtKB:P07703, ECO:0000305|PubMed:26151409}.
CC   -!- SUBUNIT: Component of the RNA polymerase I (Pol I) and RNA
CC       polymerase III (Pol III) complexes consisting of at least 13 and
CC       17 subunits, respectively. {ECO:0000269|PubMed:12391170,
CC       ECO:0000269|PubMed:26151409}.
CC   -!- INTERACTION:
CC       Q8WXE1:ATRIP; NbExp=3; IntAct=EBI-1055079, EBI-747353;
CC       Q96CA5:BIRC7; NbExp=5; IntAct=EBI-1055079, EBI-517623;
CC       Q8IYA8:CCDC36; NbExp=3; IntAct=EBI-1055079, EBI-8638439;
CC       Q5VWN6-2:FAM208B; NbExp=3; IntAct=EBI-1055079, EBI-10172380;
CC       Q9UKT9:IKZF3; NbExp=7; IntAct=EBI-1055079, EBI-747204;
CC       Q719H9:KCTD1; NbExp=5; IntAct=EBI-1055079, EBI-9027502;
CC       P08727:KRT19; NbExp=3; IntAct=EBI-1055079, EBI-742756;
CC       Q9BRK4:LZTS2; NbExp=3; IntAct=EBI-1055079, EBI-741037;
CC       Q9NS73-5:MBIP; NbExp=3; IntAct=EBI-1055079, EBI-10182361;
CC       Q13064:MKRN3; NbExp=4; IntAct=EBI-1055079, EBI-2340269;
CC       P15531:NME1; NbExp=7; IntAct=EBI-1055079, EBI-741141;
CC       Q9Y2S0:POLR1D; NbExp=11; IntAct=EBI-1055079, EBI-359498;
CC       P52435:POLR2J; NbExp=8; IntAct=EBI-1055079, EBI-394753;
CC       Q969Q6:PPP2R3C; NbExp=5; IntAct=EBI-1055079, EBI-2561661;
CC       Q9UFD9:RIMBP3; NbExp=5; IntAct=EBI-1055079, EBI-10182375;
CC       Q8IYX7:SAXO1; NbExp=3; IntAct=EBI-1055079, EBI-3957636;
CC       Q16637:SMN2; NbExp=5; IntAct=EBI-1055079, EBI-395421;
CC       Q8NA61-2:SPERT; NbExp=4; IntAct=EBI-1055079, EBI-11524851;
CC       P15884:TCF4; NbExp=3; IntAct=EBI-1055079, EBI-533224;
CC       Q9UBB9:TFIP11; NbExp=4; IntAct=EBI-1055079, EBI-1105213;
CC       Q13829:TNFAIP1; NbExp=6; IntAct=EBI-1055079, EBI-2505861;
CC       P14373:TRIM27; NbExp=5; IntAct=EBI-1055079, EBI-719493;
CC       Q9Y3Q8:TSC22D4; NbExp=5; IntAct=EBI-1055079, EBI-739485;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:26151409}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O15160-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O15160-2; Sequence=VSP_005913;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Treacher Collins syndrome 3 (TCS3) [MIM:248390]: A form
CC       of Treacher Collins syndrome, a disorder of craniofacial
CC       development. Treacher Collins syndrome is characterized by a
CC       combination of bilateral downward slanting of the palpebral
CC       fissures, colobomas of the lower eyelids with a paucity of
CC       eyelashes medial to the defect, hypoplasia of the facial bones,
CC       cleft palate, malformation of the external ears, atresia of the
CC       external auditory canals, and bilateral conductive hearing loss.
CC       {ECO:0000269|PubMed:21131976, ECO:0000269|PubMed:26151409}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Leukodystrophy, hypomyelinating, 11 (HLD11) [MIM:616494]:
CC       An autosomal recessive neurologic disorder characterized by brain
CC       hypomyelination, delayed psychomotor development, intellectual
CC       disability, tremor and other neurologic symptoms. Some patients
CC       may additionally manifest non-neurologic features, particularly
CC       dental abnormalities and hypogonadotropic hypogonadism.
CC       {ECO:0000269|PubMed:26151409}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the archaeal RpoD/eukaryotic RPB3 RNA
CC       polymerase subunit family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF008442; AAC14354.1; -; mRNA.
DR   EMBL; AF047441; AAC39892.1; -; mRNA.
DR   EMBL; AL355802; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC008863; AAH08863.1; -; mRNA.
DR   CCDS; CCDS4901.1; -. [O15160-1]
DR   RefSeq; NP_001305805.1; NM_001318876.1. [O15160-2]
DR   RefSeq; NP_976035.1; NM_203290.3. [O15160-1]
DR   UniGene; Hs.743509; -.
DR   ProteinModelPortal; O15160; -.
DR   BioGrid; 114909; 104.
DR   DIP; DIP-27587N; -.
DR   IntAct; O15160; 107.
DR   MINT; MINT-1137932; -.
DR   STRING; 9606.ENSP00000361465; -.
DR   iPTMnet; O15160; -.
DR   PhosphoSitePlus; O15160; -.
DR   BioMuta; POLR1C; -.
DR   REPRODUCTION-2DPAGE; IPI00217386; -.
DR   SWISS-2DPAGE; O15160; -.
DR   EPD; O15160; -.
DR   MaxQB; O15160; -.
DR   PaxDb; O15160; -.
DR   PeptideAtlas; O15160; -.
DR   PRIDE; O15160; -.
DR   DNASU; 9533; -.
DR   Ensembl; ENST00000304004; ENSP00000307212; ENSG00000171453. [O15160-2]
DR   Ensembl; ENST00000372389; ENSP00000361465; ENSG00000171453. [O15160-1]
DR   GeneID; 9533; -.
DR   KEGG; hsa:9533; -.
DR   UCSC; uc003ovn.4; human. [O15160-1]
DR   CTD; 9533; -.
DR   DisGeNET; 9533; -.
DR   GeneCards; POLR1C; -.
DR   GeneReviews; POLR1C; -.
DR   H-InvDB; HIX0005907; -.
DR   HGNC; HGNC:20194; POLR1C.
DR   HPA; HPA031010; -.
DR   MalaCards; POLR1C; -.
DR   MIM; 248390; phenotype.
DR   MIM; 610060; gene.
DR   MIM; 616494; phenotype.
DR   neXtProt; NX_O15160; -.
DR   OpenTargets; ENSG00000171453; -.
DR   Orphanet; 861; Treacher-Collins syndrome.
DR   PharmGKB; PA134882004; -.
DR   eggNOG; KOG1521; Eukaryota.
DR   eggNOG; COG0202; LUCA.
DR   GeneTree; ENSGT00550000075060; -.
DR   HOGENOM; HOG000230845; -.
DR   HOVERGEN; HBG017743; -.
DR   InParanoid; O15160; -.
DR   KO; K03027; -.
DR   OMA; GKCQRFL; -.
DR   OrthoDB; EOG091G03FZ; -.
DR   PhylomeDB; O15160; -.
DR   TreeFam; TF103034; -.
DR   Reactome; R-HSA-1834949; Cytosolic sensors of pathogen-associated DNA.
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-HSA-73762; RNA Polymerase I Transcription Initiation.
DR   Reactome; R-HSA-73772; RNA Polymerase I Promoter Escape.
DR   Reactome; R-HSA-73777; RNA Polymerase I Chain Elongation.
DR   Reactome; R-HSA-73780; RNA Polymerase III Chain Elongation.
DR   Reactome; R-HSA-73863; RNA Polymerase I Transcription Termination.
DR   Reactome; R-HSA-73980; RNA Polymerase III Transcription Termination.
DR   Reactome; R-HSA-749476; RNA Polymerase III Abortive And Retractive Initiation.
DR   Reactome; R-HSA-76061; RNA Polymerase III Transcription Initiation From Type 1 Promoter.
DR   Reactome; R-HSA-76066; RNA Polymerase III Transcription Initiation From Type 2 Promoter.
DR   Reactome; R-HSA-76071; RNA Polymerase III Transcription Initiation From Type 3 Promoter.
DR   GeneWiki; POLR1C; -.
DR   GenomeRNAi; 9533; -.
DR   PRO; PR:O15160; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000171453; -.
DR   CleanEx; HS_POLR1C; -.
DR   CleanEx; HS_POLR1E; -.
DR   ExpressionAtlas; O15160; baseline and differential.
DR   Genevisible; O15160; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005736; C:DNA-directed RNA polymerase I complex; IBA:GO_Central.
DR   GO; GO:0005666; C:DNA-directed RNA polymerase III complex; IDA:MGI.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0003899; F:DNA-directed 5'-3' RNA polymerase activity; TAS:ProtInc.
DR   GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.
DR   GO; GO:0045815; P:positive regulation of gene expression, epigenetic; TAS:Reactome.
DR   GO; GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome.
DR   GO; GO:0006363; P:termination of RNA polymerase I transcription; TAS:Reactome.
DR   GO; GO:0006362; P:transcription elongation from RNA polymerase I promoter; TAS:Reactome.
DR   GO; GO:0006360; P:transcription from RNA polymerase I promoter; TAS:ProtInc.
DR   GO; GO:0006383; P:transcription from RNA polymerase III promoter; IEA:GOC.
DR   GO; GO:0006361; P:transcription initiation from RNA polymerase I promoter; TAS:Reactome.
DR   CDD; cd07032; RNAP_I_II_AC40; 1.
DR   Gene3D; 2.170.120.12; -; 1.
DR   InterPro; IPR001514; DNA-dir_RNA_pol_30-40kDasu_CS.
DR   InterPro; IPR011262; DNA-dir_RNA_pol_insert.
DR   InterPro; IPR011263; DNA-dir_RNA_pol_RpoA/D/Rpb3.
DR   InterPro; IPR009025; RBP11-like_dimer.
DR   InterPro; IPR033901; RNAPI/II_AC40.
DR   PANTHER; PTHR11800:SF15; PTHR11800:SF15; 1.
DR   Pfam; PF01000; RNA_pol_A_bac; 1.
DR   Pfam; PF01193; RNA_pol_L; 1.
DR   SMART; SM00662; RPOLD; 1.
DR   SUPFAM; SSF55257; SSF55257; 2.
DR   SUPFAM; SSF56553; SSF56553; 1.
DR   PROSITE; PS00446; RNA_POL_D_30KD; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Disease mutation;
KW   DNA-directed RNA polymerase; Leukodystrophy; Nucleus; Phosphoprotein;
KW   Reference proteome; Transcription.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.5}.
FT   CHAIN         2    346       DNA-directed RNA polymerases I and III
FT                                subunit RPAC1.
FT                                /FTId=PRO_0000132739.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.5}.
FT   MOD_RES       4      4       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     308    346       FSVESTGVLPPDVLVSEAIKVLMGKCRRFLDELDAVQMD
FT                                -> CKKDLLAAVAHTCNPSTLGGQGEWITGSRERDHPG
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:9653160}.
FT                                /FTId=VSP_005913.
FT   VARIANT      26     26       T -> I (in HLD11; dbSNP:rs796052126).
FT                                {ECO:0000269|PubMed:26151409}.
FT                                /FTId=VAR_074655.
FT   VARIANT      32     32       N -> I (in HLD11; decreased localization
FT                                to the nucleus and retained in the
FT                                cytoplasm; loss of association with RNA
FT                                polymerase III-transcribed genes;
FT                                decreased association with RNA polymerase
FT                                III complex; probably prevents RNA
FT                                polymerase III complex assembly and
FT                                activity; dbSNP:rs796052124).
FT                                {ECO:0000269|PubMed:26151409}.
FT                                /FTId=VAR_074656.
FT   VARIANT      65     65       M -> V (in HLD11; dbSNP:rs141471029).
FT                                {ECO:0000269|PubMed:26151409}.
FT                                /FTId=VAR_074657.
FT   VARIANT      74     74       N -> S (in HLD11; decreased localization
FT                                to the nucleus and retained in the
FT                                cytoplasm; loss of association with RNA
FT                                polymerase III-transcribed genes;
FT                                decreased association with RNA polymerase
FT                                III complex; probably prevents RNA
FT                                polymerase III complex assembly and
FT                                activity; dbSNP:rs371802902).
FT                                {ECO:0000269|PubMed:26151409}.
FT                                /FTId=VAR_074658.
FT   VARIANT      94     94       V -> A (in HLD11).
FT                                {ECO:0000269|PubMed:26151409}.
FT                                /FTId=VAR_074659.
FT   VARIANT     109    109       R -> H (in HLD11; dbSNP:rs796052127).
FT                                {ECO:0000269|PubMed:26151409}.
FT                                /FTId=VAR_074660.
FT   VARIANT     132    132       G -> D (in HLD11; dbSNP:rs201320592).
FT                                {ECO:0000269|PubMed:26151409}.
FT                                /FTId=VAR_074661.
FT   VARIANT     146    146       C -> R (in HLD11; dbSNP:rs796052125).
FT                                {ECO:0000269|PubMed:26151409}.
FT                                /FTId=VAR_074662.
FT   VARIANT     191    191       R -> Q (in HLD11; dbSNP:rs373046018).
FT                                {ECO:0000269|PubMed:26151409}.
FT                                /FTId=VAR_074663.
FT   VARIANT     262    262       I -> T (in HLD11; dbSNP:rs751006626).
FT                                {ECO:0000269|PubMed:26151409}.
FT                                /FTId=VAR_074664.
FT   VARIANT     279    279       R -> Q (in TCS3; no effect on
FT                                localization to the nucleus; no effect on
FT                                association with RNA polymerase I and RNA
FT                                polymerase III complexes;
FT                                dbSNP:rs191582628).
FT                                {ECO:0000269|PubMed:21131976,
FT                                ECO:0000269|PubMed:26151409}.
FT                                /FTId=VAR_064899.
FT   VARIANT     279    279       R -> W (in TCS3; dbSNP:rs141156009).
FT                                {ECO:0000269|PubMed:21131976}.
FT                                /FTId=VAR_064900.
FT   VARIANT     295    295       Missing (in HLD11).
FT                                {ECO:0000269|PubMed:26151409}.
FT                                /FTId=VAR_074665.
FT   VARIANT     324    324       E -> K (in HLD11).
FT                                {ECO:0000269|PubMed:26151409}.
FT                                /FTId=VAR_074666.
SQ   SEQUENCE   346 AA;  39250 MW;  B7D558BC8F33D92E CRC64;
     MAASQAVEEM RSRVVLGEFG VRNVHTTDFP GNYSGYDDAW DQDRFEKNFR VDVVHMDENS
     LEFDMVGIDA AIANAFRRIL LAEVPTMAVE KVLVYNNTSI VQDEILAHRL GLIPIHADPR
     LFEYRNQGDE EGTEIDTLQF RLQVRCTRNP HAAKDSSDPN ELYVNHKVYT RHMTWIPLGN
     QADLFPEGTI RPVHDDILIA QLRPGQEIDL LMHCVKGIGK DHAKFSPVAT ASYRLLPDIT
     LLEPVEGEAA EELSRCFSPG VIEVQEVQGK KVARVANPRL DTFSREIFRN EKLKKVVRLA
     RVRDHYIFSV ESTGVLPPDV LVSEAIKVLM GKCRRFLDEL DAVQMD
//
